OLIVIA KEENAN: Open Payments
NPI 1275189334 · WOODHAVEN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,904 in 175 payments from 18 companies in 2025. Trend: 2023 $1,313 · 2024 $2,853 · 2025 $2,904
Food & beverage: $2,904
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 25 | $579 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 18 | $444 |
| Janssen Biotech, Inc. | 33 | $312 |
| ABBVIE INC. | 27 | $298 |
| Amgen Inc. | 13 | $277 |
| E.R. Squibb & Sons, L.L.C. | 14 | $233 |
| Galderma Laboratories, L.P. | 19 | $211 |
| Organon LLC | 9 | $179 |
| LNHC, Inc | 1 | $68 |
| Lilly USA, LLC | 3 | $64 |
Products named: Bimzelx, ILUMYA, TREMFYA, OTEZLA, Sotyktu, SKYRIZI, NEMLUVIO, RINVOQ.
Industry payments across MI — which companies pay providers there.
